Also in this section

• News Home
• News Archive
• Limited access to cardiovascular treatments in the world's largest populations is causing increasing inequity between rich and poor
• Iron is the key to reducing infant mortality in China, according to new study
• $12million to combat cardiovascular disease
• Landmark documentary series highlights global health issues
• Indigenous Australian patients confused and frustrated by kidney disease
• Kidney dysfunction markers a clue to coronary heart disease
• Can a polypill protect heart health?
• George Institute Director awarded 2008 Young Tall Poppy of Science
• Kidney disease, child road injury and back pain projects among NHMRC grants for the Institute
• Low back pain trial now recruiting in Sydney
• Leading Institute stroke specialist wins prestigious RPA Research Medal
• Communications, partnerships critical in improving Indigenous health
• Presentations from Cardiovascular and Metabolic Medicine meeting 2008 now available
• Weight watching in China
• Scaling-up HIV interventions in India
• Preventing depression after stroke
• Cracking the problem of whiplash
• ADVANCE trial shows combined treatments provide 33% reduction of serious kidney complications in type 2 diabetes
• 'China too must confront obesity' according to Institute researchers
• The George Institute, China now able to host Fogarty International Clinical Research Fellows
• United Arab Emirates and Australia join forces in health and safety research
• Salt warning on sausage sizzles!
• Low back pain recovery slow: and worse for those on compensation
• Fiona Turnbull awarded the International Society of Hypertension AstraZeneca award
• Staff Profile - Dr Bassel Hassan
• Daily burden of epilepsy can outweigh clinical symptoms
• John Chalmers honoured with Alberto Zanchetti Life Achievement Award
• The largest ever study of diabetes shows intensive glucose control reduces serious complications
• David Jayne, Diabetes Patient & ADVANCE study participant
• Falls prevention research shows innovation is required
• Achieving global equity in treating kidney disease
• Staff Profile-Dr Vibeke Anna
• Fulbright Indigenous Scholarship: supporting young Indigenous leaders

Low back pain trial now recruiting in Sydney

The George Institute is now recruiting for their Clinical Trial of Tai Chi for Long-term Low Back Pain.

This study is open to anyone between the ages of 18 and 70yrs who have had low back pain for more than 3 months.

The study is a randomized trial: meaning that once you are enrolled in the trial, you will be randomly assigned to the tai chi intervention group, which starts the 10 week tai chi program right away or to the wait-list control group which starts the tai chi program 10 weeks time.

If you are interested in learning more about this study please contact:

Amanda Hall - PhD Candidate
The George Institute
Phone: 61 2 9657 0391
Mobile: 61 4 2086 2757
Email: amandahall@george.org.au

The TAI CHI Study Email Poster [PDF 340KB]